Logo image of AB9.DE

ABO ENERGY GMBH & CO. KGAA (AB9.DE) Stock Fundamental Analysis

FRA:AB9 - DE0005760029 - Common Stock

35.8 EUR
+0.3 (+0.85%)
Last: 9/11/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AB9. AB9 was compared to 20 industry peers in the Independent Power and Renewable Electricity Producers industry. AB9 has only an average score on both its financial health and profitability. AB9 is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AB9 had positive earnings in the past year.
AB9 had a negative operating cash flow in the past year.
In the past 5 years AB9 has always been profitable.
In the past 5 years AB9 reported 4 times negative operating cash flow.
AB9.DE Yearly Net Income VS EBIT VS OCF VS FCFAB9.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

1.2 Ratios

AB9's Return On Assets of 3.90% is fine compared to the rest of the industry. AB9 outperforms 80.00% of its industry peers.
AB9's Return On Equity of 11.31% is fine compared to the rest of the industry. AB9 outperforms 75.00% of its industry peers.
AB9 has a better Return On Invested Capital (6.94%) than 85.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AB9 is above the industry average of 5.19%.
Industry RankSector Rank
ROA 3.9%
ROE 11.31%
ROIC 6.94%
ROA(3y)4.95%
ROA(5y)4.95%
ROE(3y)12.64%
ROE(5y)10.99%
ROIC(3y)8.37%
ROIC(5y)8.5%
AB9.DE Yearly ROA, ROE, ROICAB9.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

AB9 has a Profit Margin (5.73%) which is in line with its industry peers.
In the last couple of years the Profit Margin of AB9 has declined.
AB9 has a Operating Margin of 13.72%. This is comparable to the rest of the industry: AB9 outperforms 55.00% of its industry peers.
AB9's Operating Margin has declined in the last couple of years.
The Gross Margin of AB9 (47.73%) is better than 65.00% of its industry peers.
AB9's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.72%
PM (TTM) 5.73%
GM 47.73%
OM growth 3Y-15.15%
OM growth 5Y-7.85%
PM growth 3Y-19.18%
PM growth 5Y-8.69%
GM growth 3Y-17.78%
GM growth 5Y-6.12%
AB9.DE Yearly Profit, Operating, Gross MarginsAB9.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

AB9 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
AB9 has about the same amout of shares outstanding than it did 1 year ago.
AB9 has more shares outstanding than it did 5 years ago.
AB9 has a worse debt/assets ratio than last year.
AB9.DE Yearly Shares OutstandingAB9.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
AB9.DE Yearly Total Debt VS Total AssetsAB9.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.92 indicates that AB9 is not a great score, but indicates only limited risk for bankruptcy at the moment.
AB9 has a better Altman-Z score (2.92) than 75.00% of its industry peers.
A Debt/Equity ratio of 1.39 is on the high side and indicates that AB9 has dependencies on debt financing.
AB9 has a Debt to Equity ratio of 1.39. This is in the lower half of the industry: AB9 underperforms 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF N/A
Altman-Z 2.92
ROIC/WACC1.29
WACC5.4%
AB9.DE Yearly LT Debt VS Equity VS FCFAB9.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 10.60 indicates that AB9 has no problem at all paying its short term obligations.
With an excellent Current ratio value of 10.60, AB9 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
AB9 has a Quick Ratio of 6.73. This indicates that AB9 is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of AB9 (6.73) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 10.6
Quick Ratio 6.73
AB9.DE Yearly Current Assets VS Current LiabilitesAB9.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

7

3. Growth

3.1 Past

AB9 shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.10%.
Measured over the past years, AB9 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.46% on average per year.
AB9 shows a strong growth in Revenue. In the last year, the Revenue has grown by 48.95%.
Measured over the past years, AB9 shows a very strong growth in Revenue. The Revenue has been growing by 28.73% on average per year.
EPS 1Y (TTM)-6.1%
EPS 3Y22.69%
EPS 5Y14.46%
EPS Q2Q%-22.61%
Revenue 1Y (TTM)48.95%
Revenue growth 3Y52%
Revenue growth 5Y28.73%
Sales Q2Q%91.62%

3.2 Future

Based on estimates for the next years, AB9 will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.76% on average per year.
Based on estimates for the next years, AB9 will show a quite strong growth in Revenue. The Revenue will grow by 10.60% on average per year.
EPS Next Y28.77%
EPS Next 2Y26.5%
EPS Next 3Y22.94%
EPS Next 5Y16.76%
Revenue Next Year5.29%
Revenue Next 2Y10.37%
Revenue Next 3Y11.05%
Revenue Next 5Y10.6%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AB9.DE Yearly Revenue VS EstimatesAB9.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
AB9.DE Yearly EPS VS EstimatesAB9.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.92, AB9 is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of AB9 indicates a somewhat cheap valuation: AB9 is cheaper than 75.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of AB9 to the average of the S&P500 Index (27.43), we can say AB9 is valued rather cheaply.
A Price/Forward Earnings ratio of 9.92 indicates a reasonable valuation of AB9.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AB9 indicates a rather cheap valuation: AB9 is cheaper than 90.00% of the companies listed in the same industry.
AB9 is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.92
Fwd PE 9.92
AB9.DE Price Earnings VS Forward Price EarningsAB9.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AB9 indicates a somewhat cheap valuation: AB9 is cheaper than 70.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.54
AB9.DE Per share dataAB9.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

AB9's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AB9's earnings are expected to grow with 22.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)0.89
EPS Next 2Y26.5%
EPS Next 3Y22.94%

5

5. Dividend

5.1 Amount

AB9 has a Yearly Dividend Yield of 1.81%.
AB9's Dividend Yield is comparable with the industry average which is at 3.57.
Compared to the average S&P500 Dividend Yield of 2.45, AB9 is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.81%

5.2 History

The dividend of AB9 is nicely growing with an annual growth rate of 7.99%!
Dividend Growth(5Y)7.99%
Div Incr Years3
Div Non Decr Years3
AB9.DE Yearly Dividends per shareAB9.DE Yearly Dividends per shareYearly Dividends per share 2020 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

21.63% of the earnings are spent on dividend by AB9. This is a low number and sustainable payout ratio.
AB9's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP21.63%
EPS Next 2Y26.5%
EPS Next 3Y22.94%
AB9.DE Yearly Income VS Free CF VS DividendAB9.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M
AB9.DE Dividend Payout.AB9.DE Dividend Payout, showing the Payout Ratio.AB9.DE Dividend Payout.PayoutRetained Earnings

ABO ENERGY GMBH & CO. KGAA

FRA:AB9 (9/11/2025, 7:00:00 PM)

35.8

+0.3 (+0.85%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)03-24 2025-03-24/amc
Earnings (Next)N/A N/A
Inst Owners2.5%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap330.08M
Analysts85.71
Price Target103.7 (189.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.81%
Yearly Dividend0.6
Dividend Growth(5Y)7.99%
DP21.63%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.79%
EPS NY rev (3m)0.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 12.92
Fwd PE 9.92
P/S 0.74
P/FCF N/A
P/OCF N/A
P/B 1.46
P/tB 1.46
EV/EBITDA 8.54
EPS(TTM)2.77
EY7.74%
EPS(NY)3.61
Fwd EY10.08%
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS48.41
BVpS24.55
TBVpS24.45
PEG (NY)0.45
PEG (5Y)0.89
Profitability
Industry RankSector Rank
ROA 3.9%
ROE 11.31%
ROCE 10.25%
ROIC 6.94%
ROICexc 8.02%
ROICexgc 8.04%
OM 13.72%
PM (TTM) 5.73%
GM 47.73%
FCFM N/A
ROA(3y)4.95%
ROA(5y)4.95%
ROE(3y)12.64%
ROE(5y)10.99%
ROIC(3y)8.37%
ROIC(5y)8.5%
ROICexc(3y)10.05%
ROICexc(5y)10.24%
ROICexgc(3y)10.08%
ROICexgc(5y)10.48%
ROCE(3y)12.36%
ROCE(5y)12.55%
ROICexcg growth 3Y3.15%
ROICexcg growth 5Y-2.54%
ROICexc growth 3Y3.3%
ROICexc growth 5Y-0.83%
OM growth 3Y-15.15%
OM growth 5Y-7.85%
PM growth 3Y-19.18%
PM growth 5Y-8.69%
GM growth 3Y-17.78%
GM growth 5Y-6.12%
F-Score3
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF N/A
Debt/EBITDA 4.81
Cap/Depr 93.06%
Cap/Sales 0.89%
Interest Coverage 5.35
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.6
Quick Ratio 6.73
Altman-Z 2.92
F-Score3
WACC5.4%
ROIC/WACC1.29
Cap/Depr(3y)101.35%
Cap/Depr(5y)118.81%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.1%
EPS 3Y22.69%
EPS 5Y14.46%
EPS Q2Q%-22.61%
EPS Next Y28.77%
EPS Next 2Y26.5%
EPS Next 3Y22.94%
EPS Next 5Y16.76%
Revenue 1Y (TTM)48.95%
Revenue growth 3Y52%
Revenue growth 5Y28.73%
Sales Q2Q%91.62%
Revenue Next Year5.29%
Revenue Next 2Y10.37%
Revenue Next 3Y11.05%
Revenue Next 5Y10.6%
EBIT growth 1Y11.32%
EBIT growth 3Y28.98%
EBIT growth 5Y18.62%
EBIT Next Year65.62%
EBIT Next 3Y30.59%
EBIT Next 5YN/A
FCF growth 1Y89.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.74%
OCF growth 3YN/A
OCF growth 5YN/A